English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/149861
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice

AuthorsBorrego, Belén ORCID; Rodríguez Pulido, Miguel Ramón CSIC ORCID; Mateos, Francisco; Losa, Nuria de la; Sobrino Castelló, Francisco; Sáiz, Margarita CSIC ORCID
KeywordsVaccine adjuvant
RNA delivery
FMD vaccine
Issue Date2013
CitationVaccine 31: 4375- 4381 (2013)
AbstractWe have recently described the antiviral effect in mice of in vitro-transcribed RNAs mimicking structural domains in the non-coding regions of the foot-and-mouth disease virus (FMDV) genome RNA. These small, synthetic and non-infectious RNA molecules (ncRNAs) are potent type-I interferon (IFN) inducers in vivo. In this work, the immunomodulatory effect of the ncRNA corresponding to the internal ribosome entry site (IRES) on immunization with two different FMD vaccine formulations, both based on inactivated virus, including or not a commercial adjuvant, was analyzed in the mice model. The effect of the time interval between RNA inoculation and immunization was also studied. RNA delivery consistently increased the titers of specific anti-FMDV antibodies, including neutralizing antibodies, elicited after vaccination. Moreover, at day 2 after immunization, significant differences in mean antibody titers could be detected between the groups of mice receiving either vaccine co-administered with the RNA and the control group, unlike those immunized with the vaccine alone. When vaccinated mice were challenged with FMDV, the mean values of viral load were lower in the groups receiving the RNA together with the vaccine. Our results show the enhancing effect of the IRES RNA on the immune response elicited after vaccination and suggest the potential of this molecule as an adjuvant for new FMD vaccine design. © 2013 Elsevier Ltd.
Identifiersdoi: 10.1016/j.vaccine.2013.07.008
issn: 0264-410X
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
SáizM_DeliveryOfSynthetic.pdf376,17 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.